From earnouts tied to policy retention to SBA-backed buyouts and equity rollovers — here's how smart buyers and sellers are closing insurance agency deals in the $1M–$5M revenue range.
Life and health insurance agencies are among the most structurally complex businesses to acquire in the lower middle market — not because the businesses are complicated, but because the value is tied almost entirely to human relationships and recurring commission streams that can evaporate if the transition is mishandled. The right deal structure must protect the buyer against client attrition and carrier appointment disruption while giving the seller a realistic path to full value realization. Most deals in this space layer two or three financing mechanisms together: an SBA 7(a) loan covering the bulk of the purchase price, a seller note or earnout component tied to book retention milestones, and occasionally an equity rollover that keeps the seller engaged as a producing agent post-close. Multiples for well-documented agencies with strong persistency rates typically range from 2.5x to 4.5x recurring annual commissions, with the actual structure determining whether the seller achieves the high or low end of that range. Understanding the three primary deal structures — asset purchases with earnouts, SBA-financed buyouts with seller notes, and equity rollovers — is essential for both parties before entering serious negotiations.
Find Insurance Agency (Life & Health) Businesses For SaleAsset Purchase with Client Retention Earnout
The buyer acquires the book of business, carrier appointments, and operating assets of the agency. A portion of the purchase price — typically 20–35% — is held back and paid out over 12–24 months based on verified client retention milestones. Retention is measured against the policy count and commission volume at closing, with earnout payments triggered at 90-day, 12-month, and 24-month intervals.
Pros
Cons
Best for: First-time buyers acquiring an owner-operated agency where the seller held most client relationships directly, and where independent verification of renewal rates is difficult pre-close.
SBA 7(a) Loan with Seller Financing Standby Note
The buyer finances 70–80% of the purchase price through an SBA 7(a) loan and the seller carries a subordinated note for 10–20% of the deal, typically on full standby for 24 months per SBA requirements. The buyer contributes 10% equity injection. This structure allows the seller to receive the majority of proceeds at close while the seller note signals confidence in the book's continuity.
Pros
Cons
Best for: Established agencies with 3+ years of clean financials, documented commission statements from multiple carriers, and a licensed team that will remain post-close. Ideal for buyers who want maximum leverage and sellers who want near-full liquidity at closing.
Equity Rollover with Phased Buyout
The seller rolls 20–40% of their equity into the acquiring entity — a regional brokerage, PE-backed aggregator, or newly formed holding company — while receiving cash for the remaining 60–80% at close. The seller continues as a licensed producer, retains client relationships, and participates in upside through their retained equity stake. A defined buyout option or put/call mechanism allows the seller to liquidate remaining equity over 3–5 years.
Pros
Cons
Best for: Sellers joining PE-backed insurance aggregators or regional brokerages executing roll-up strategies, particularly where the seller is under 60 and willing to continue producing in exchange for platform resources and deferred upside.
Sole Practitioner Medicare Agency — Retirement Sale
$1,200,000
$720,000 SBA 7(a) loan (60%), $360,000 cash from buyer equity and additional SBA draw (30%), $120,000 seller note on 24-month standby (10%)
Seller receives $1,080,000 at close. Seller note of $120,000 at 6% interest becomes active after 24-month standby period and is repaid over 36 months. No earnout. Seller agrees to 90-day consulting transition and signs a 3-year non-solicitation agreement. Carrier appointments confirmed transferable pre-close with written carrier consent letters in hand.
Mid-Size Group Benefits Agency — Buyer-Seller Earnout Deal
$2,800,000
$1,960,000 at close (70%), $840,000 earnout paid over 24 months tied to client retention milestones (30%)
Earnout measured at 12 months (50% of holdback released if trailing commissions are at or above 90% of closing baseline) and at 24 months (remaining 50% released if commissions remain at or above 85% of baseline). Seller stays on as a W-2 producer for 18 months at $120,000 annual salary. Non-solicitation clause runs 5 years. All carrier appointments confirmed transferable with written consent from top 4 carriers prior to close.
Regional Life & Health Brokerage Joining PE Aggregator
$4,500,000
$3,150,000 cash at close (70%), $1,350,000 equity rollover into aggregator holding company at agreed valuation (30%)
Seller retains 30% equity stake in the acquiring platform valued at current book multiple. Put option allows seller to sell remaining equity at 18-month trailing EBITDA multiple (floor of 4.0x, cap of 6.0x) any time after 36 months from close. Seller continues as licensed producing principal for minimum 3 years. Non-compete runs concurrent with equity holding period plus 12 months post-exit.
Find Insurance Agency (Life & Health) Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
Most well-documented life and health insurance agencies with strong renewal rates and diversified carrier relationships sell for 2.5x to 4.5x recurring annual commissions. Agencies with persistency rates above 90%, documented CRM systems, and a retained producer team command the high end of that range. Owner-centric books with concentration risk or thin documentation typically transact at 2.5x to 3.0x, often with a meaningful earnout component rather than full cash at close.
In a life and health agency deal, earnouts are almost always tied to client or commission retention rather than future growth. The buyer establishes a baseline of trailing 12-month commissions at close, then measures actual commission revenue at 12 and 24 months post-close. If retention holds above a defined threshold — typically 85–90% of the baseline — earnout payments are released. If retention falls short, the holdback is reduced proportionally. The key negotiation points are the measurement dates, the baseline definition, and whether carrier-driven commission rate changes count against the seller.
Yes. SBA 7(a) loans are commonly used to finance life and health insurance agency acquisitions, and many SBA lenders with experience in professional services are comfortable underwriting commission-based recurring revenue as qualifying cash flow. The agency will need to show 2–3 years of clean financials with commissions documented by carrier and product line, and the buyer must contribute at least 10% equity. Sellers are typically required to carry a subordinated note of 10–20% on a 24-month standby per SBA guidelines. Pre-qualifying your deal with an SBA lender experienced in insurance agency transactions is strongly recommended before going under LOI.
Carrier appointments are one of the most critical — and frequently overlooked — elements of an insurance agency acquisition. Most carrier agreements do not automatically transfer with a sale of the business. The buyer must apply for new appointments or obtain written consent from each carrier to assume the existing appointment. Some carriers will grant continuity letters; others require the buyer to go through a full appointment process, which can take 30–90 days. If preferred commission tier status is at risk, this should be negotiated directly with the carrier before close. Never assume appointments transfer automatically — confirm it in writing from every material carrier before signing a purchase agreement.
The best protection against earnout erosion starts before the sale. Sellers should spend 12–18 months pre-sale transitioning client relationships from themselves personally to a CRM system and licensed team members, so renewals are not dependent on the owner's continued involvement. During deal negotiations, sellers should push for narrow and clearly defined retention metrics, short earnout windows (12 months preferred over 24), exclusions for losses driven by carrier commission changes outside the seller's control, and a consulting agreement that keeps the seller engaged and visible to top accounts throughout the earnout period.
Most life and health insurance agency acquisitions are structured as asset purchases rather than stock sales, primarily because buyers want to acquire the book of business and carrier appointments without assuming unknown liabilities — including E&O exposure, regulatory violations, or contractual obligations tied to the legal entity. Sellers, however, often prefer stock sales for tax reasons, as gains on stock are typically treated as long-term capital gains rather than ordinary income. The tax difference can be meaningful on a $2M–$4M deal. If a stock sale is on the table, buyers will require extensive indemnification provisions, reps and warranties insurance, and a thorough E&O history review. Consulting a tax advisor who understands insurance agency transactions early in the process is essential for both sides.
More Insurance Agency (Life & Health) Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers